GB8716324D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB8716324D0
GB8716324D0 GB878716324A GB8716324A GB8716324D0 GB 8716324 D0 GB8716324 D0 GB 8716324D0 GB 878716324 A GB878716324 A GB 878716324A GB 8716324 A GB8716324 A GB 8716324A GB 8716324 D0 GB8716324 D0 GB 8716324D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB878716324A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB878716324A priority Critical patent/GB8716324D0/en
Publication of GB8716324D0 publication Critical patent/GB8716324D0/en
Priority to DE3822557A priority patent/DE3822557C2/en
Priority to DE3845000A priority patent/DE3845000C2/en
Priority to CH2556/88A priority patent/CH677449A5/de
Priority to GB8816024A priority patent/GB2208200B/en
Priority to MYPI88000750A priority patent/MY103746A/en
Priority to MYPI93000569A priority patent/MY109309A/en
Priority to IE209188A priority patent/IE61908B1/en
Priority to AU18893/88A priority patent/AU618270B2/en
Priority to GR880100458A priority patent/GR1000172B/en
Priority to NZ225340A priority patent/NZ225340A/en
Priority to DK198803854A priority patent/DK174125B1/en
Priority to SE8802569A priority patent/SE503191C2/en
Priority to HU883604A priority patent/HU203480B/en
Priority to HU906980A priority patent/HU206271B/en
Priority to LU87268A priority patent/LU87268A1/en
Priority to NL8801734A priority patent/NL194823C/en
Priority to PT87957A priority patent/PT87957B/en
Priority to ZA884941A priority patent/ZA884941B/en
Priority to IL87044A priority patent/IL87044A0/en
Priority to NO883054A priority patent/NO179359C/en
Priority to CA000571592A priority patent/CA1328402C/en
Priority to AT0177788A priority patent/AT402896B/en
Priority to FI883261A priority patent/FI93308C/en
Priority to ES8802161A priority patent/ES2010561A6/en
Priority to FR888809439A priority patent/FR2617714B1/en
Priority to KR1019880008590A priority patent/KR100195894B1/en
Priority to JP63171703A priority patent/JP2578477B2/en
Priority to IT8848173A priority patent/IT1224673B/en
Priority to BE8800803A priority patent/BE1001079A4/en
Priority to GB9027324A priority patent/GB2239178B/en
Priority to CS914115A priority patent/CS411591A3/en
Priority to SG36/92A priority patent/SG3692G/en
Priority to SG3592A priority patent/SG3592G/en
Priority to HK165/92A priority patent/HK16592A/en
Priority to HK164/92A priority patent/HK16492A/en
Priority to CY1631A priority patent/CY1631A/en
Priority to CY1632A priority patent/CY1632A/en
Priority to SE19939301290A priority patent/SE9301290D0/en
Priority to JP1994073170A priority patent/JP2764041B6/en
Priority to US08/471,706 priority patent/US5753618A/en
Priority to US09/022,079 priority patent/US6066616A/en
Priority to DK200100558A priority patent/DK174476B1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB878716324A 1987-07-10 1987-07-10 Organic compounds Pending GB8716324D0 (en)

Priority Applications (43)

Application Number Priority Date Filing Date Title
GB878716324A GB8716324D0 (en) 1987-07-10 1987-07-10 Organic compounds
DE3822557A DE3822557C2 (en) 1987-07-10 1988-07-04 Medicines containing somatostatins
DE3845000A DE3845000C2 (en) 1987-07-10 1988-07-04 Compsn. contg. somatostatin analogues for treating breast cancer
CH2556/88A CH677449A5 (en) 1987-07-10 1988-07-05
GB8816024A GB2208200B (en) 1987-07-10 1988-07-06 Pharmaceutical compositions of somatostatin analogues
MYPI88000750A MY103746A (en) 1987-07-10 1988-07-07 Improvements in or relating to somatostatins
MYPI93000569A MY109309A (en) 1987-07-10 1988-07-07 Improvements in or relating to somatostatins
FR888809439A FR2617714B1 (en) 1987-07-10 1988-07-08 PHARMACEUTICAL COMPOSITION BASED ON SOMATOSTATIN ANALOGS
NO883054A NO179359C (en) 1987-07-10 1988-07-08 Process for the preparation of pharmaceutical preparations containing somatostatin analogues.
NL8801734A NL194823C (en) 1987-07-10 1988-07-08 Injection solution of a somatostatin analogue.
GR880100458A GR1000172B (en) 1987-07-10 1988-07-08 Improvements relating to somatostatines
NZ225340A NZ225340A (en) 1987-07-10 1988-07-08 Pharmaceutical compositions comprising somatostatin analogues and lactic acid
DK198803854A DK174125B1 (en) 1987-07-10 1988-07-08 Pharmaceutical preparation for parenteral administration containing a somatostatin analogue, lactic acid and a basic compound
SE8802569A SE503191C2 (en) 1987-07-10 1988-07-08 Pharmaceutical composition containing a somatostatin analogue and its use
HU883604A HU203480B (en) 1987-07-10 1988-07-08 Process for producing parenteral pharmaceutical compositions containing somatostatin analogues as active components
HU906980A HU206271B (en) 1987-07-10 1988-07-08 Process for producing pharmaceutical compositions against breast cancer, comprising somatostatin analog as active ingredient
LU87268A LU87268A1 (en) 1987-07-10 1988-07-08 PHARMACEUTICAL COMPOSITION BASED ON SOMATOSTATIN ANALOGS
AU18893/88A AU618270B2 (en) 1987-07-10 1988-07-08 Improvements in or relating to organic compounds
PT87957A PT87957B (en) 1987-07-10 1988-07-08 Process for the preparation of a pharmaceutical composition containing a Somatatostan analogue
ZA884941A ZA884941B (en) 1987-07-10 1988-07-08 Somatostatins
IL87044A IL87044A0 (en) 1987-07-10 1988-07-08 Pharmaceutical compositions comprising somatostatin analogues
IE209188A IE61908B1 (en) 1987-07-10 1988-07-08 "Improvements in or relating to somatostatins"
CA000571592A CA1328402C (en) 1987-07-10 1988-07-08 Somatostatins
AT0177788A AT402896B (en) 1987-07-10 1988-07-08 Pharmaceutical preparation based on somatostatins
FI883261A FI93308C (en) 1987-07-10 1988-07-08 A process for the preparation of a pharmaceutical composition comprising a somatostatin analogue
ES8802161A ES2010561A6 (en) 1987-07-10 1988-07-08 Somatostatin analogue composition and use in treating breast cancer
JP63171703A JP2578477B2 (en) 1987-07-10 1988-07-09 Improvements on softstatins
KR1019880008590A KR100195894B1 (en) 1987-07-10 1988-07-09 Pharmaceutical compositions containing somatostatin analogues
BE8800803A BE1001079A4 (en) 1987-07-10 1988-07-11 Pharmaceutical composition based similar somatostatin.
IT8848173A IT1224673B (en) 1987-07-10 1988-07-11 PHARMACEUTICAL COMPOSITION INCLUDING AN ANALOG OF SOMATOSTATIN ESUO USE IN THE TREATMENT OF BREAST CANCER
GB9027324A GB2239178B (en) 1987-07-10 1990-12-18 Somatostatin analogues for the treatment of breast cancer
CS914115A CS411591A3 (en) 1987-07-10 1991-12-27 Pharmaceutical composition and its application for mastocarcinoma treatment
SG36/92A SG3692G (en) 1987-07-10 1992-01-13 Pharmaceutical compositions of somatostatin analogues
SG3592A SG3592G (en) 1987-07-10 1992-01-13 Somatostatin analogues for the treatment of breast cancer
HK165/92A HK16592A (en) 1987-07-10 1992-02-27 Somatostatin analogues for the treatment of breast cancer
HK164/92A HK16492A (en) 1987-07-10 1992-02-27 Pharmaceutical compositions of somatostatin analogues
CY1631A CY1631A (en) 1987-07-10 1992-07-10 Pharmaceutical compositions of somatostatin analogues
CY1632A CY1632A (en) 1987-07-10 1992-07-10 Somatostatin analogues for the treatment of breast cancer
SE19939301290A SE9301290D0 (en) 1987-07-10 1993-04-20 USE OF A SOMATOSTATIN ANALOGUE
JP1994073170A JP2764041B6 (en) 1987-07-10 1994-04-12 Improvements on somatostatins
US08/471,706 US5753618A (en) 1987-07-10 1995-06-06 Somatostatin analogue composition and use in treating breast cancer
US09/022,079 US6066616A (en) 1987-07-10 1998-02-11 Somatostatin analogue composition and use in treating breast cancer
DK200100558A DK174476B1 (en) 1987-07-10 2001-04-04 Compsn. contg. somatostatin analogues for treating breast cancer - having lactic acid to improve tolerance when injected

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878716324A GB8716324D0 (en) 1987-07-10 1987-07-10 Organic compounds

Publications (1)

Publication Number Publication Date
GB8716324D0 true GB8716324D0 (en) 1987-08-19

Family

ID=10620471

Family Applications (1)

Application Number Title Priority Date Filing Date
GB878716324A Pending GB8716324D0 (en) 1987-07-10 1987-07-10 Organic compounds

Country Status (6)

Country Link
KR (1) KR100195894B1 (en)
AT (1) AT402896B (en)
GB (1) GB8716324D0 (en)
HU (1) HU206271B (en)
IT (1) IT1224673B (en)
ZA (1) ZA884941B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008528A1 (en) 1996-08-30 1998-03-05 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
EP3624829A4 (en) 2017-05-15 2020-10-28 Sun Pharmaceutical Industries Limited Octreotide injection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions

Also Published As

Publication number Publication date
KR890001583A (en) 1989-03-27
ATA177788A (en) 1997-02-15
IT1224673B (en) 1990-10-18
HU206271B (en) 1992-10-28
IT8848173A0 (en) 1988-07-11
AT402896B (en) 1997-09-25
HU906980D0 (en) 1991-05-28
KR100195894B1 (en) 1999-06-15
ZA884941B (en) 1990-03-28

Similar Documents

Publication Publication Date Title
GB8708833D0 (en) Organic compounds
GB8704328D0 (en) Organic compounds
GB8716324D0 (en) Organic compounds
GB8714087D0 (en) Organic compounds
GB8701273D0 (en) Organic compounds
GB8703424D0 (en) Organic compounds
GB8703423D0 (en) Organic compounds
GB8702578D0 (en) Organic compounds
GB8702577D0 (en) Organic compounds
GB8702576D0 (en) Organic compounds
GB8702575D0 (en) Organic compounds
GB8702129D0 (en) Organic compounds
GB8702128D0 (en) Organic compounds
GB8701644D0 (en) Organic compounds
GB8701643D0 (en) Organic compounds
GB8714085D0 (en) Organic compounds
GB8701059D0 (en) Organic compounds
GB8700607D0 (en) Organic compounds
GB8703428D0 (en) Organic compounds
GB8703429D0 (en) Organic compounds
GB8703427D0 (en) Organic compounds
GB8703432D0 (en) Organic compounds
GB8714088D0 (en) Organic compounds
GB8708816D0 (en) Organic compounds
GB8708815D0 (en) Organic compounds